Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Behavioral activation therapy intervention is a structured, empirically-supported psychotherapy that aims to help individuals—primarily those with depression—overcome withdrawal and avoidance by systematically increasing engagement in activities that provide positive reinforcement and align with their values[1][2][3][4][5][6]. It operates within the framework of cognitive behavioral therapy and is based on the behavioral model of depression, which attributes depressive symptoms partly to reduced positive reinforcement from the environment due to withdrawal and inactivity. Behavioral activation typically involves identifying avoidance patterns, planning and scheduling rewarding activities, and monitoring both activity and mood, often leading to symptom improvement in depression and related conditions[2][3][4][5][6].\n\nBehavioral activation is not a target for drugs, has no known molecular interactions, and does not fit into molecular or receptor classifications. It is classified as a psychotherapeutic or psychological intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Behavioral activation therapy intervention (BA).